34 results
8-K
EX-1.1
OLMA
Olema Pharmaceuticals, Inc.
5 Jan 24
Entry into a Material Definitive Agreement
5:26pm
) Each employee benefit plan, within the meaning of Section 3(3) of the Employee Retirement Income Security Act of 1974, as amended (“ERISA … recently completed fiscal year; or (B) a material increase in the Company and its subsidiaries’ “accumulated post-retirement benefit obligations” (within
8-K
EX-10.1
wvub4c
5 Sep 23
Olema Oncology Announces Combined Financing for Up to $180 Million
7:39am
8-K
EX-10.2
rnvuc0ztp4x1p sax6
5 Sep 23
Olema Oncology Announces Combined Financing for Up to $180 Million
7:39am
S-3
EX-4.3
00vpkdnzp10zbvj
28 Feb 22
Shelf registration
6:34pm
8-K
EX-99.1
qaprxywc7vgr
28 Feb 22
Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:39pm
8-K
EX-99.1
izx3xoa9 2ahhx
10 Nov 21
Olema Oncology Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:19pm
10-Q
EX-10.1
n0mvt8vro wa
11 May 21
Quarterly report
4:22pm
DEF 14A
lljorhg8j2res
27 Apr 21
Definitive proxy
4:06pm
10-K
hjo1gy
17 Mar 21
Annual report
4:21pm
8-K
EX-99.1
k0q25xuwasebv
17 Mar 21
Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates
4:18pm